Bimekizumab treatment in biologic dmard-naive patients with active psoriatic arthritis: 52-week efficacy and safety results from a phase 3, randomised, placebo-controlled, active reference study
ARTHRITIS & RHEUMATOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要